Together, these data confirm the role of KLF8 and the KLF8/OGT loop in promoting stemness and chemoresistance of triple negative breast cancer cell, which may be used to develop strategy in BCSCs-specific treatment. The gene discussed is KLF8; the disease is triple-negative breast carcinoma.